Myriad Genetics, Inc. Share Price
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.18 USD | +1.11% | -1.73% | -5.02% |
20/03 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
27/02 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Sales 2024 * | 828M 69.03B | Sales 2025 * | 897M 74.75B | Capitalization | 1.64B 137B |
---|---|---|---|---|---|
Net income 2024 * | -91M -7.59B | Net income 2025 * | -64M -5.34B | EV / Sales 2024 * | 1.96 x |
Net cash position 2024 * | 21.96M 1.83B | Net Debt 2025 * | 10.91M 910M | EV / Sales 2025 * | 1.85 x |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
-29.3
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Myriad Genetics, Inc.
1 day | +1.11% | ||
1 week | -1.73% | ||
Current month | -14.73% | ||
1 month | -15.40% | ||
3 months | -18.18% | ||
6 months | +27.94% | ||
Current year | -5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 13/20/13 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | 29/01 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 16/09/16 |
Paul Bisaro
BRD | Director/Board Member | 63 | 31/22/31 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 27/20/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 16 M€ | -8.49% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 18.18 | +1.11% | 518,695 |
25/24/25 | 17.98 | -3.49% | 582,160 |
24/24/24 | 18.63 | +0.16% | 481,133 |
23/24/23 | 18.6 | +0.59% | 508,160 |
22/24/22 | 18.49 | -0.05% | 485,015 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.02% | 1.64B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- MYGN Stock